The results of the study were staggering. At 18th month after initial treatment Half (48.4%) reported prescription opioid use during past month. Also, treatment response to brief bup-nx treatment was overwhelmingly poor, only 7% had successful opioid use outcome. The opioid agonist treatment and participation in extended treatment phase had the best outcome 16.7% success rate. Of particular interest is that in this population, the multivariable analysis in this study showed that greater pain severity at baseline was directly linked to opioid dependence at 18
The results of the study were staggering. At 18th month after initial treatment Half (48.4%) reported prescription opioid use during past month. Also, treatment response to brief bup-nx treatment was overwhelmingly poor, only 7% had successful opioid use outcome. The opioid agonist treatment and participation in extended treatment phase had the best outcome 16.7% success rate. Of particular interest is that in this population, the multivariable analysis in this study showed that greater pain severity at baseline was directly linked to opioid dependence at 18